Bracco Imaging Receives Regulatory Approval in China for SonoVue in the Assessment of Fallopian Tube Patency
New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced…
Ericsson Receives Frost & Sullivan’s 2025 Global SASE for the Distributed Enterprise Enabling Technology Leadership Recognition for Excellence in Cellular-Optimized Secure Networking
Recognized for driving digital innovation and customer success through unmatched application diversity,…
BingX AI Delivers All-Round Analysis for Better-Informed Trading
PANAMA CITY, Aug. 5, 2025 /PRNewswire/ -- BingX, a leading cryptocurrency exchange…
ROLLER Launches Summer Ebook for Aspiring Attraction Entrepreneurs
From concept to business plan, ROLLER is helping aspiring operators with the…
Phoenix Palladium Unveils Gourmet Village: South Mumbai’s Landmark for Global Flavors
A unique gastronomic destination uniting world-class restaurants under one roof, spanning an…
Wyser launches AgentikX, India’s first-ever Agentic AI Investment Initiative for Enterprise B2B Startups through its maiden fund
BANGALORE, India, Aug. 5, 2025 /PRNewswire/ -- Wyser announces AgentikX, India's first Agentic…
Intas Pharmaceuticals Launches HETRONIFLY (Serplulimab), India’s First Novel Immunotherapy for Advanced Small Cell Lung Cancer
AHMEDABAD, India, Aug. 5, 2025 /PRNewswire/ -- Intas Pharmaceuticals has launched HETRONIFLY™…
Virtune AB (Publ) (“Virtune”) has completed the monthly rebalancing for July 2025 of its Virtune Crypto Top 10 Index ETP – the first crypto index ETP in the Nordics
August 05, 2025 07:04 ET | Source: Virtune AB (Publ) Stockholm, 5…
Tensive appointsmedical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
Has more than 30 years of experience bringing innovations to market, including…
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
First patient in Phase I/II clinical trial expected to be enrolled in…
